徐建明, 张华. 西妥昔单抗单药或与伊立替康联合治疗伊立替康耐药的转移性结直肠癌[J]. 循证医学, 2006, 6(5): 274-276. DOI: 10.3969/j.issn.1671-5144.2006.05.006
    引用本文: 徐建明, 张华. 西妥昔单抗单药或与伊立替康联合治疗伊立替康耐药的转移性结直肠癌[J]. 循证医学, 2006, 6(5): 274-276. DOI: 10.3969/j.issn.1671-5144.2006.05.006
    XU Jian-ming, ZHANG Hua. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(5): 274-276. DOI: 10.3969/j.issn.1671-5144.2006.05.006
    Citation: XU Jian-ming, ZHANG Hua. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(5): 274-276. DOI: 10.3969/j.issn.1671-5144.2006.05.006

    西妥昔单抗单药或与伊立替康联合治疗伊立替康耐药的转移性结直肠癌

    Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

    /

    返回文章
    返回